АНТИРЕФЛЮКСНАЯ РЕЗЕКЦИЯ СЛИЗИСТОЙ ОБОЛОЧКИ ПИЩЕВОДНО-ЖЕЛУДОЧНОГО СОУСТЬЯ В ЛЕЧЕНИИ ПИЩЕВОДА БАРРЕТТА: ПЕРВЫЙ ОПЫТ

Antireflux resection of mucous membrane of esophagogastric anastomosis (ARMS) was performed on 6 patients with typical symptoms of gastroesophageal reflux disease (GERD). The patients had a short segment of сolumnar-celled metaplasia (1-2 cm) without radiological and endoscopic signs of hiatal hernia. All the patients received medicamentous therapy by antisecretory agents more than 3 years. The operation included the endoscopic resection of²/3 circle of mucous membrane of esophagogastric anastomosis and resection of the area of columnar-celled metaplasia. The results of treatment were assessed during 3-7 months after ARMS. There was noted an absence of clinical manifestations of GERD, regression of inflammatory signs of mucous coat of esophagus in 4 out of 6 patients. Symptoms of GERD remained in 2 patients, although the intensity of signs significantly decreased.

гастроэзофагеальная рефлюксная болезнь, пищевод Барретта, цилиндроклеточная метаплазия пищевода, эндоскопическая резекция слизистой оболочки пищеводно-желудочного перехода

1. Anderson L., Murray L., Murphy S. et al. Mortality in Barrett’s oeso phagus: results from a population based study // Gut. 2003. Vol. 52. P. 1081-1084.

2. Antoniou S., Koch O., Kaindlstorfer A. et al. Endoscopic full-thickness plication versus laparoscopic fundoplication: a prospective study on quality of life and symptom control // Surg. Endosc. 2012. Vol. 26. P. 1063-1068.

3. Bani-Hani K., Bani-Hani B. Columnar-lined esophagus: time to drop the eponym of «Barrett»: historical review // J. Gastroenterol. Hepatol. 2008. Vol. 23. P. 707-715.

4. Barnes W., Hoddinott K., Mundy S. et al. Transoral incisionless fundoplication offers high patient satisfaction and relief of therapy-resistant typical and atypical symptoms of GERD in community practice // Surg. Innov. 2011. Vol. 18. P. 119-129.

5. Caygill C., Watson A., Lao-Sirieix P. et al. Barrett’s oesophagus and adenocarcinoma // W. J. Surg. Oncol. 2004. Vol. 2. P. 1-21.

6. Fitzgerald R., di Pietro M., Ragunath K. et al. British Society of Gastroenterology guidelines on the diagnosis and management of Barrett’s oesophagus // Gut. 2014. Vol. 63. P. 7-63.

7. Hofstetter W., Peters J., DeMeester T. et al. Long-term outcome of antireflux surgery in patients with Barrett’s esophagus // Ann. Surg. 2011. Vol. 234. P. 532-539.

8. Inoue H., Ito Y., Ikeda H. et al. Antireflux mucosectomy for gastroesophageal reflux disease in the absence of hiatus hernia: a pilot study // Ann. Gastroenterol. 2014. Vol. 27. P. 346-351.

9. Löfdahl H., Lu Y., Lagergren P., Lagergren J. Risk factors for esophageal adenocarcinoma after antireflux surgery // Ann. Surg. 2013. Vol. 257. P. 579-582.

10. Maret-Ouda J, Konings P., Lagergren J., Brusselaers N. Antireflux surgery and risk of esophageal adenocarcinoma: a systematic review and meta-analysis // Ann. Surg. 2016. Vol. 263. P. 251-257.

11. Melhado R., Alderson D., Tucker O. The changing face of esophageal cancer // Cancers. 2010. Vol. 2. P. 1379-1404.

12. Mudan S., Kang J-Y. Epidemiology and clinical presentation in esophageal cancer // Cambridge University Press. 2008. P. 1-10.

13. Narsule C., Burch M., Ebright M. et al. Endoscopic fundoplication for the treatment of gastroesophageal reflux disease: initial experience // J. Thorac. Cardiovasc. Surg. 2012. Vol. 143. P. 228-234.

14. Ozawa S., Kumai K., Higuchi K. et al. Short-term and long-term outcome of endoluminal gastroplication for the treatment of GERD: the first multicenter trial in Japan // J. Gastroenterol. 2009. Vol. 44. P. 675-684.

15. Shaheen N., Falk G., Iyer P., Gerson L. ACG Clinical Guideline: diagnosis and management of Barrett’s esophagus // Am. J. Gastroenterol. 2016. Vol. 111. P. 30-50.

16. Sharma P. Barrett’s esophagus // N. Engl. J. Med. 2009. Vol. 361. P. 2548-2556.

17. Spechler S., Sharma P., Souza R. et al. American Gastroenterological Association medical position statement on the management of Barrett’s esophagus // Gastroenterology. 2011. Vol. 140. P. 1084-1091.

18. Stefanidis D., Hope W., Kohn G. et al. Guidelines for surgical treat ment of gastroesophageal reflux disease // Surg. Endosc. 2010. Vol. 24. P. 2647-2669.

19. Testoni P., Vailati C., Testoni S. et al. Transoral incisionless fundoplication (TIF 2.0) with EsophyX for gastroesophageal reflux disease: long-term results and findings affecting outcome // Surg. Endosc. 2012. Vol. 26. P. 1425-1435.

20. Wang K., Sampliner R. Updated guidelines 2008 for the diagnosis, surveillance and therapy of Barrett’s esophagus // Am. J. Gastroenterol. 2008. Vol. 103. P. 788-797.